DEBANJAN RAY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DEBANJAN RAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DEBANJAN RAY. DEBANJAN RAY is Chief Financial Officer in CytomX Therapeutics, Inc. ($CTMX).
Latest Insider Trading Transactions of DEBANJAN RAY
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2019 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | A | 16.85 | 90,000 | 1,516,500 | 90,000 | |
| Dec 14 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.45 | 3,000 | 4,347 | 7,220 | |
| Dec 14 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 15.00 | 3,000 | 45,000 | 5,928 | 8.9 K to 5.9 K (-33.60 %) |
| Dec 14 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.45 | 3,000 | 4,347 | 8,928 | 5.9 K to 8.9 K (+50.61 %) |
| Oct 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.45 | 3,000 | 4,347 | 13,220 | |
| Oct 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 18.46 | 3,000 | 55,380 | 5,928 | 8.9 K to 5.9 K (-33.60 %) |
| Oct 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.45 | 3,000 | 4,347 | 8,928 | 5.9 K to 8.9 K (+50.61 %) |
| Sep 06 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.45 | 3,000 | 4,347 | 16,220 | |
| Sep 06 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 22.39 | 3,000 | 67,170 | 5,928 | 8.9 K to 5.9 K (-33.60 %) |
| Sep 06 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.45 | 3,000 | 4,347 | 8,928 | 5.9 K to 8.9 K (+50.61 %) |
| Aug 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.45 | 290 | 420 | 19,220 | |
| Aug 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.45 | 290 | 420 | 19,220 | |
| Aug 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.26 | 2,710 | 3,414 | 0 | |
| Aug 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.26 | 2,710 | 3,414 | 0 | |
| Aug 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 26.05 | 3,000 | 78,150 | 5,928 | 8.9 K to 5.9 K (-33.60 %) |
| Aug 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 26.05 | 3,000 | 78,150 | 5,928 | 8.9 K to 5.9 K (-33.60 %) |
| Aug 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.45 | 290 | 420 | 8,928 | 8.6 K to 8.9 K (+3.36 %) |
| Aug 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.45 | 290 | 420 | 8,928 | 8.6 K to 8.9 K (+3.36 %) |
| Aug 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.26 | 2,710 | 3,414 | 8,638 | 5.9 K to 8.6 K (+45.72 %) |
| Aug 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.26 | 2,710 | 3,414 | 8,638 | 5.9 K to 8.6 K (+45.72 %) |
| Jul 03 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.26 | 3,000 | 3,780 | 2,710 | |
| Jul 03 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 22.56 | 3,000 | 67,680 | 5,928 | 8.9 K to 5.9 K (-33.60 %) |
| Jul 03 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.26 | 3,000 | 3,780 | 8,928 | 5.9 K to 8.9 K (+50.61 %) |
| Jun 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.26 | 3,000 | 3,780 | 5,710 | |
| Jun 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 25.93 | 3,000 | 77,793 | 5,928 | 8.9 K to 5.9 K (-33.60 %) |
| Jun 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.26 | 3,000 | 3,780 | 8,928 | 5.9 K to 8.9 K (+50.61 %) |
| Jun 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Grant | A | 17.90 | 1,187 | 21,248 | 5,928 | 4.7 K to 5.9 K (+25.04 %) |
| May 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.26 | 3,000 | 3,780 | 8,710 | |
| May 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 26.52 | 3,000 | 79,562 | 4,741 | 7.7 K to 4.7 K (-38.75 %) |
| May 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.26 | 3,000 | 3,780 | 7,741 | 4.7 K to 7.7 K (+63.28 %) |
| Apr 04 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.26 | 3,000 | 3,780 | 11,710 | |
| Apr 04 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 28.12 | 3,000 | 84,360 | 4,741 | 7.7 K to 4.7 K (-38.75 %) |
| Apr 04 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.26 | 3,000 | 3,780 | 7,741 | 4.7 K to 7.7 K (+63.28 %) |
| Mar 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.13 | 14,485 | 16,425 | 20,000 | |
| Mar 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.26 | 5,515 | 6,948 | 14,710 | |
| Mar 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | M | 1.26 | 13,000 | 16,379 | 20,225 | |
| Mar 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 31.02 | 1,944 | 60,293 | 4,741 | 6.7 K to 4.7 K (-29.08 %) |
| Mar 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 30.41 | 12,541 | 381,384 | 6,685 | 19.2 K to 6.7 K (-65.23 %) |
| Mar 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.13 | 14,485 | 16,425 | 19,226 | 4.7 K to 19.2 K (+305.53 %) |
| Mar 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 30.06 | 5,515 | 165,775 | 4,741 | 10.3 K to 4.7 K (-53.77 %) |
| Mar 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.26 | 5,515 | 6,948 | 10,256 | 4.7 K to 10.3 K (+116.33 %) |
| Mar 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 29.40 | 13,000 | 382,242 | 4,741 | 17.7 K to 4.7 K (-73.28 %) |
| Mar 05 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Buy | M | 1.26 | 13,000 | 16,379 | 17,741 | 4.7 K to 17.7 K (+274.20 %) |
| Feb 02 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 26.69 | 2,548 | 68,010 | 4,741 | 7.3 K to 4.7 K (-34.96 %) |
| Jan 26 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Option Exercise | A | 25.82 | 100,000 | 2,582,000 | 100,000 | |
| Jan 03 2018 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 21.11 | 2,500 | 52,775 | 7,289 | 9.8 K to 7.3 K (-25.54 %) |
| Dec 05 2017 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 20.58 | 2,500 | 51,450 | 9,789 | 12.3 K to 9.8 K (-20.34 %) |
| Dec 05 2017 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Grant | A | 12.15 | 163 | 1,980 | 12,289 | 12.1 K to 12.3 K (+1.34 %) |
| Oct 04 2017 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 18.10 | 2,500 | 45,250 | 14,626 | 17.1 K to 14.6 K (-14.60 %) |
| Sep 05 2017 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 17.17 | 2,500 | 42,925 | 17,126 | 19.6 K to 17.1 K (-12.74 %) |
| Aug 11 2017 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 15.00 | 2,500 | 37,500 | 19,626 | 22.1 K to 19.6 K (-11.30 %) |
| Jul 06 2017 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Sell | S | 15.47 | 2,500 | 38,675 | 22,126 | 24.6 K to 22.1 K (-10.15 %) |
| Jun 02 2017 | CTMX | CytomX Therapeutic ... | RAY DEBANJAN | Chief Financial Off ... | Grant | A | 8.68 | 2,698 | 23,415 | 24,626 | 21.9 K to 24.6 K (+12.30 %) |
Page: 1